Skip to main content
. 2016 Jun 23;7(30):48375–48390. doi: 10.18632/oncotarget.10237

Figure 2. Forest plot for the hazard ratio of progression-free survival with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Figure 2

AC, adjuvant chemotherapy; CCRT, concurrent chemoradiotherapy; CI, confidence interval; HR, hazard ratio; NACT, neoadjuvant chemotherapy; O-E, observed minus expected events.